Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey G P
Department of Medical Specialties, University of Texas MD Anderson Cancer Center, Houston 77030.
Infect Control Hosp Epidemiol. 1992 Apr;13(4):215-21. doi: 10.1086/646512.
To determine the impact of catheter management on the acute and long-term outcome of catheter-related coagulase-negative staphylococcal bacteremia.
Retrospective surveillance of catheter-related sepsis using quantitative blood and catheter cultures.
University-affiliated tertiary cancer center.
Seventy patients with catheter-related coagulase-negative staphylococcal bacteremia were studied by retrospective chart review. The clinical characteristics of the patients and the management of the bacteremias were determined. The impact of immunosuppressive risk factors, antibiotic therapy, and catheter management on the recurrence of the bacteremia was investigated.
Acute sepsis-related morbidity and mortality were not related to catheter management. However, during a 12-week followup period, the bacteremia recurred in 20% of the patients whose catheters remained in place, compared with only 3% of those whose catheters were removed (p less than .05). By multivariate analysis, patients whose catheters remained in place were 2.9 times more likely to experience a recurrence than those whose catheters were removed (odds ratio = 2.9, 95% confidence interval = 1.2-8.8, p = .03). All other potential risk factors were equally distributed between patients, with and without a recurrence.
Although patients with catheter-related coagulase-negative staphylococcal bacteremia could be treated successfully while the catheter remains in place with the majority remaining free of recurrence, catheter retention results in a significantly higher risk for the recurrence of the bacteremia.
确定导管管理对导管相关凝固酶阴性葡萄球菌菌血症的急性和长期结局的影响。
采用定量血液和导管培养对导管相关脓毒症进行回顾性监测。
大学附属三级癌症中心。
通过回顾性病历审查研究了70例导管相关凝固酶阴性葡萄球菌菌血症患者。确定了患者的临床特征和菌血症的管理情况。研究了免疫抑制风险因素、抗生素治疗和导管管理对菌血症复发的影响。
急性脓毒症相关的发病率和死亡率与导管管理无关。然而,在12周的随访期内,导管留置患者中有20%菌血症复发,而导管拔除患者中只有3%复发(p<0.05)。多因素分析显示,导管留置患者复发的可能性是导管拔除患者的2.9倍(比值比=2.9,95%置信区间=1.2-8.8,p=0.03)。所有其他潜在风险因素在有复发和无复发的患者中分布均匀。
虽然导管相关凝固酶阴性葡萄球菌菌血症患者在导管留置的情况下可以成功治疗,大多数患者不会复发,但导管留置会导致菌血症复发的风险显著更高。